{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:02:19Z","timestamp":1785265339322,"version":"3.55.0"},"reference-count":88,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Infection by SARS-CoV-2 may elicit uncontrolled and damaging inflammatory responses. Thus, it is critical to identify compounds able to inhibit virus replication and thwart the inflammatory reaction. Here, we show that the plasma levels of the immunoregulatory neuropeptide VIP are elevated in patients with severe COVID-19, correlating with reduced inflammatory mediators and with survival on those patients. In vitro, vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP), highly similar neuropeptides, decreased the SARS-CoV-2 RNA content in human monocytes and viral production in lung epithelial cells, also reducing cell death. Both neuropeptides inhibited the production of proinflammatory mediators in lung epithelial cells and in monocytes. VIP and PACAP prevented in monocytes the SARS-CoV-2-induced activation of NF-kB and SREBP1 and SREBP2, transcriptions factors involved in proinflammatory reactions and lipid metabolism, respectively. They also promoted CREB activation, a transcription factor with antiapoptotic activity and negative regulator of NF-kB. Specific inhibition of NF-kB and SREBP1\/2 reproduced the anti-inflammatory, antiviral, and cell death protection effects of VIP and PACAP. Our results support further clinical investigations of these neuropeptides against COVID-19.<\/jats:p>","DOI":"10.1002\/jlb.5cova1121-626r","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T19:44:50Z","timestamp":1648151090000},"page":"1107-1121","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells"],"prefix":"10.1093","volume":"111","author":[{"given":"Jairo R","family":"Temerozo","sequence":"first","affiliation":[{"name":"Laboratory on Thymus Research, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"},{"name":"National Institute for Science and Technology on Neuroimmunomodulation, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Q","family":"Sacramento","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Fintelman-Rodrigues","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila R R","family":"P\u00e3o","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S","family":"de Freitas","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suelen Silva Gomes","family":"Dias","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 C","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz , Rio de Janeiro, RJ, Brazil"},{"name":"Igua\u00e7u University , Nova Igua\u00e7u, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayara","family":"Mattos","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius Cardoso","family":"Soares","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"},{"name":"Program of Immunology and Inflammation, Federal University of Rio de Janeiro, UFRJ , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaclaudia G","family":"Azevedo-Quintanilha","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio D","family":"Hottz","sequence":"additional","affiliation":[{"name":"Laboratory of Immunothrombosis, Department of Biochemistry, Federal University of Juiz de Fora (UFJF) , Juiz de Fora, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Kurtz","sequence":"additional","affiliation":[{"name":"Paulo Niemeyer State Brain Institute , Rio de Janeiro, RJ, Brazil"},{"name":"D'Or Institute for Research and Education , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando A","family":"Bozza","sequence":"additional","affiliation":[{"name":"D'Or Institute for Research and Education , Rio de Janeiro, RJ, Brazil"},{"name":"Evandro Chagas National Institute of Infectious Diseases , Fiocruz, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia T","family":"Bozza","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Moreno L","family":"Souza","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"},{"name":"National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT\/IDPN), Center for Technological Development in Health (CDTS), Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumith Chequer","family":"Bou-Habib","sequence":"additional","affiliation":[{"name":"Laboratory on Thymus Research, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"},{"name":"National Institute for Science and Technology on Neuroimmunomodulation, Oswaldo Cruz Institute, Fiocruz , Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3389\/fimmu.2020.01441","article-title":"Immune response, inflammation, and the clinical spectrum of COVID-19","volume":"11","author":"Garc\u00eda","year":"2020","journal-title":"Front Immunol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"e1008536","DOI":"10.1371\/journal.ppat.1008536","article-title":"The hallmarks of COVID-19 disease","volume":"16","author":"Tang","year":"2020","journal-title":"PLoS Pathog"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front Immunol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"e20201129","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras","year":"2020","journal-title":"J Exp Med"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"e20201012","DOI":"10.1084\/jem.20201012","article-title":"Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19","volume":"217","author":"Radermecker","year":"2020","journal-title":"J Exp Med"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor\u2013enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J Clin Invest"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"e20201707","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-cov-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2020","journal-title":"J Exp Med"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41420-021-00428-w","article-title":"SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes","volume":"7","author":"Ferreira","year":"2021","journal-title":"Cell Death Discov"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(03)13413-7","article-title":"Lung pathology of fatal severe acute respiratory syndrome","volume":"361","author":"Nicholls","year":"2003","journal-title":"Lancet"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J Exp Med"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1016\/S2666-5247(20)30144-0","article-title":"Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study","volume":"1","author":"Schurink","year":"2020","journal-title":"The Lancet Microbe"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3389\/fphar.2020.572009","article-title":"Targeting neutrophils to treat acute respiratory distress syndrome in coronavirus disease","volume":"11","author":"Chiang","year":"2020","journal-title":"Front Pharmacol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/infdis\/jit504","article-title":"Active replication of middle east respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis","volume":"209","author":"Zhou","year":"2014","journal-title":"J Infect Dis"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1099\/jgv.0.000351","article-title":"Middle east respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells","volume":"97","author":"Tynell","year":"2016","journal-title":"J Gen Virol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pharmthera.2008.11.006","article-title":"From ligands to function","volume":"121","author":"Dickson","year":"2009","journal-title":"Pharmacol Ther"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/154411130201300303","article-title":"Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity","volume":"13","author":"Ganea","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1523\/JNEUROSCI.20-10-03622.2000","article-title":"Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-\u03b1 production in injured spinal cord and in activated microglia via a cAMP-dependent pathway","volume":"20","author":"Kim","year":"2000","journal-title":"J Neurosci"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.intimp.2007.05.017","article-title":"VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice","volume":"7","author":"Larocca","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbi.2007.07.004","article-title":"Vasoactive intestinal peptide inhibits cycloxygenase-2 expression in activated macrophages, microglia, and dendritic cells","volume":"22","author":"Gonzalez-Rey","year":"2008","journal-title":"Brain Behav Immun"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-5728(99)00023-5","article-title":"VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFN\u03b3 synthesis by T cells","volume":"96","author":"Delgado","year":"1999","journal-title":"J Neuroimmunol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.4049\/jimmunol.162.8.4685","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation","volume":"162","author":"Delgado","year":"1999","journal-title":"J Immunol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MED.0b013e328342568a","article-title":"VIP and PACAP: recent insights into their functions\/roles in physiology and disease from molecular and genetic studies","volume":"18","author":"Moody","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2174\/138161207780618966","article-title":"Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator","volume":"13","author":"Gonzalez-Rey","year":"2007","journal-title":"Curr Pharm Des"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.peptides.2007.04.008","article-title":"Tuning immune tolerance with vasoactive intestinal peptide: A new therapeutic approach for immune disorders","volume":"28","author":"Pozo","year":"2007","journal-title":"Peptides"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/ijms21010065","article-title":"A clinical approach for the use of VIP axis in inflammatory and autoimmune diseases","volume":"21","author":"Mart\u00ednez","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023032109032414600_","volume-title":"Real-time RT-PCR primers and probes for COVID-19","author":"CDC","year":"2020"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000328636","article-title":"Neuropeptides as pleiotropic modulators of the immune response","volume":"94","author":"Souza-Moreira","year":"2011","journal-title":"Neuroendocrinology"},{"key":"2023032109032414600_","volume-title":"Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure","author":"NCT0431169","year":"2020"},{"key":"2023032109032414600_","volume-title":"Inhaled Aviptadil for the Treatment of Moderate and Severe COVID-19","author":"NCT04536350","year":"2020"},{"key":"2023032109032414600_","volume-title":"A Clinical Study Evaluating Inhaled Aviptadil on COVID-19","author":"NCT04844580","year":"2021"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/infdis\/jiab044","article-title":"Monocytes and macrophages, targets of severe acute respiratory syndrome coronavirus 2: The clue for coronavirus disease 2019 immunoparalysis","volume":"224","author":"Boumaza","year":"2021","journal-title":"J Infect Dis"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/infdis\/jiaa753","article-title":"Severe acute respiratory syndrome coronavirus 2-induced immune activation and death of monocyte-derived human macrophages and dendritic cells","volume":"223","author":"Zheng","year":"2021","journal-title":"J Infect Dis"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/sj.bjp.0705597","article-title":"Activation of VPAC 1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion","volume":"141","author":"D\u00e9rand","year":"2004","journal-title":"Br J Pharmacol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0196-9781(99)00202-8","article-title":"Immunohistochemical localization and distribution of VIP\/PACAP receptors in human lung","volume":"21","author":"Busto","year":"2000","journal-title":"Peptides"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/labinvest.3780283","article-title":"Expression and distribution of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human airways","volume":"81","author":"Groneberg","year":"2001","journal-title":"Lab Investig"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1182\/blood.V87.12.5152.bloodjournal87125152","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27) and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosis","volume":"87","author":"Delgado","year":"1996","journal-title":"Blood"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3389\/fimmu.2018.01336","article-title":"The neuropeptides vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide control HIV-1 infection in macrophages through activation of protein kinases A and C","volume":"9","author":"Temerozo","year":"2018","journal-title":"Front Immunol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s004410050700","article-title":"Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce phosphorylation of the transcription factor CREB in subpopulations of rat pinealocytes: immunocytochemical and immunochemical evidence","volume":"286","author":"Schomerus","year":"1996","journal-title":"Cell Tissue Res"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1563-2571.2002.02010.x","article-title":"Transcriptional control of the inflammatory response: a role for the CREB-binding protein (CBP)","volume":"29","author":"Matt","year":"2002","journal-title":"Acta Med Austriaca"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","article-title":"The role of the transcription factor CREB in immune function","volume":"185","author":"Wen","year":"2010","journal-title":"J Immunol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"L418","DOI":"10.1152\/ajplung.2001.281.2.L418","article-title":"Interactions between CBP, NF-\u03baB, and CREB in the lungs after hemorrhage and endotoxemia","volume":"281","author":"Shenkar","year":"2001","journal-title":"Am J Physiol Cell Mol Physiol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1128\/MCB.24.18.8288-8300.2004","article-title":"Selective coactivator interactions in gene activation by SREBP-1a and -1c","volume":"24","author":"Toth","year":"2004","journal-title":"Mol Cell Biol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41467-018-08015-x","article-title":"SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target","volume":"10","author":"Yuan","year":"2019","journal-title":"Nat Commun"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"7901","DOI":"10.3390\/ijms21217901","article-title":"Hijacking of lipid droplets by hepatitis C, dengue and zika viruses\u2014From viral protein moonlighting to extracellular release","volume":"21","author":"Cloherty","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1128\/JVI.00337-11","article-title":"Sterol regulatory element-binding protein 2 couples HIV-1 transcription to cholesterol homeostasis and T cell activation","volume":"85","author":"Taylor","year":"2011","journal-title":"J Virol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"e1009127","DOI":"10.1371\/journal.ppat.1009127","article-title":"Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators","volume":"16","author":"Dias S da","year":"2020","journal-title":"PLoS Pathog"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107108118","article-title":"Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41392-020-00292-7","article-title":"COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm","volume":"5","author":"Lee","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.3389\/fimmu.2020.598444","article-title":"NF-\u03baB pathway as a potential target for treatment of critical stage COVID-19 patients","volume":"11","author":"Kircheis","year":"2020","journal-title":"Front Immunol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3830051","article-title":"Increased recovery and survival in patients with COVID-19 respiratory failure following treatment with aviptadil: report #1 of the ZYESAMI COVID-19 research group","author":"Youssef","year":"2021","journal-title":"SSRN Electron J"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.peptides.2007.06.007","article-title":"The discovery of VIP: Initially looked for in the lung, isolated from intestine, and identified as a neuropeptide","volume":"28","author":"Said","year":"2007","journal-title":"Peptides"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1749-6632.1999.tb07909.x","article-title":"VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal","volume":"897","author":"Delgado","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.4049\/jimmunol.159.11.5450","article-title":"Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription","volume":"159","author":"Parry","year":"1997","journal-title":"J Immunol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.1074\/jbc.271.34.20828","article-title":"Elevated cyclic AMP inhibits NF-\u03baB-mediated transcription in human monocytic cells and endothelial cells","volume":"271","author":"Ollivier","year":"1996","journal-title":"J Biol Chem"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"15642","DOI":"10.1073\/pnas.1519644112","article-title":"CREB pathway links PGE2 signaling with macrophage polarization","volume":"112","author":"Luan","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1523\/JNEUROSCI.4922-03.2004","article-title":"Suppression of proinflammatory cytokines interleukin-1 and tumor necrosis factor- in astrocytes by a v1 vasopressin receptor agonist: a cAMP response element-binding protein-dependent mechanism","volume":"24","author":"Zhao","year":"2004","journal-title":"J Neurosci"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbrc.2008.03.052","article-title":"DPPC regulates COX-2 expression in monocytes via phosphorylation of CREB","volume":"370","author":"Morris","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3389\/fimmu.2019.01788","article-title":"Exclusive temporal stimulation of IL-10 expression in LPS-stimulated mouse macrophages by cAMP inducers and Type I interferons","volume":"10","author":"Ernst","year":"2019","journal-title":"Front Immunol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.imlet.2019.06.004","article-title":"Inflammatory signal induced IL-10 production of marginal zone B-cells depends on CREB","volume":"212","author":"Bar\u00e1tki","year":"2019","journal-title":"Immunol Lett"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.molimm.2010.02.015","article-title":"Role of CREB in modulation of TNF\u03b1 and IL-10 expression in LPS-stimulated RAW264.7 macrophages","volume":"47","author":"Avni","year":"2010","journal-title":"Mol Immunol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.immuni.2005.08.010","article-title":"Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis\u2014CREB and NF-\u03baB as key regulators","volume":"23","author":"Park","year":"2005","journal-title":"Immunity"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood-2007-04-083600","article-title":"CREB is a critical regulator of normal hematopoiesis and leukemogenesis","volume":"111","author":"Cheng","year":"2008","journal-title":"Blood"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology \u2014 divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/mol.105.015776","article-title":"Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors","volume":"69","author":"Harikumar","year":"2006","journal-title":"Mol Pharmacol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1465-9921-12-45","article-title":"Prospect of vasoactive intestinal peptide therapy for COPD\/PAH and asthma: a review","volume":"12","author":"Wu","year":"2011","journal-title":"Respir Res"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.peptides.2007.04.009","article-title":"Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma\/COPD","volume":"28","author":"Onoue","year":"2007","journal-title":"Peptides"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/thorax.58.3.217","article-title":"Bronchodilation by an inhaled VPAC2 receptor agonist in patients with stable asthma","volume":"58","author":"Lind\u00e9n","year":"2003","journal-title":"Thorax"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1465-9921-12-141","article-title":"VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension","volume":"12","author":"Hamidi","year":"2011","journal-title":"Respir Res"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.peptides.2010.04.024","article-title":"Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation","volume":"31","author":"Hilaire","year":"2010","journal-title":"Peptides"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1378\/chest.130.4_MeetingAbstracts.121S-c","article-title":"Inhaled Vasoactive Intestinal Peptide (VIP) improves the 6-minute walk test and quality of life in patients with COPD: The VIP\/COPD-trial","volume":"130","author":"Burian","year":"2006","journal-title":"Chest"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1476-5381.2011.01676.x","article-title":"VPAC receptors: structure, molecular pharmacology and interaction with accessory","volume":"166","author":"Couvineau","year":"2012","journal-title":"Br J Pharmacol"},{"key":"2023032109032414600_","article-title":"Biased GPCR signaling: Possible mechanisms and inherent limitations","volume":"211","author":"Gurevich","journal-title":"Pharmacol Ther"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/edrv.21.1.0390","article-title":"Uncovering molecular mechanisms involved in activation of G protein-coupled","volume":"21","author":"Gether","year":"2000","journal-title":"Endocr Rev"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2222.1998.00198.x","article-title":"Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus","volume":"28","author":"Van Der Velden","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"L325","DOI":"10.1152\/ajplung.00294.2014","article-title":"ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets","volume":"308","author":"Dreymueller","year":"2015","journal-title":"Am J Physiol Cell Mol Physiol"},{"key":"2023032109032414600_","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1515\/hsz-2018-0114","article-title":"Kallikrein-related peptidases in lung diseases","volume":"399","author":"Bonda","year":"2018","journal-title":"Biol Chem"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/JLB.5COVA1121-626R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/JLB.5COVA1121-626R","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/111\/5\/1107\/49467355\/jlb11106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/111\/5\/1107\/49467355\/jlb11106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T01:32:04Z","timestamp":1700357524000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/111\/5\/1107\/6885246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":88,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3,24]]},"published-print":{"date-parts":[[2022,4,21]]}},"URL":"https:\/\/doi.org\/10.1002\/jlb.5cova1121-626r","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.25.220806","asserted-by":"object"}]},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5]]},"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"2021-11-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}